These data support the hypothesis that the MMR gene mutation carriers may have been predisposed to develop these particular breast cancers; that is, MMR gene mutations may initiate the development of breast cancer (as a driver) or accelerate carcinogenesis in breast cancers that occur in MMR gene mutation carriers (as an accelerator). Here, MRC1 is linked to breast cancer.